Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis

The proper dose and schedule of sunitinib have yet to be established for patients with metastatic renal cell carcinoma (RCC) on hemodialysis. We reviewed two patients with metastatic RCC on hemodialysis who had been treated with sunitinib in Yonsei Cancer Center, Yonsei University College of Medicin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Yoon, Sang Hyun, Kim, Ki Hyang, Choi, Junjeong, Kim, Gun Min, Kim, Joo Hoon, Kim, Hyo Song, Park, Young Nyun, Rha, Sun Young
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Cancer Association 2010
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953783/
https://ncbi.nlm.nih.gov/pubmed/20948925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.3.180
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi